Skip to main content
NOVAREX Co., Ltd. logo

NOVAREX Co., Ltd. — Investor Relations & Filings

Ticker · 194700 ISIN · KR7194700001 KO Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2020-03-06 Proxy Solicitation & In…
Country KR South Korea
Listing KO 194700

About NOVAREX Co., Ltd.

https://www.novarex.co.kr/en/

NOVAREX Co., Ltd. is a research and development-driven company specializing in health functional foods and supplements. It operates as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM), offering end-to-end services that encompass product planning, development, manufacturing, and delivery. Through its Life Science Research Center, the company develops novel functional ingredients validated by thorough verification and human application testing. NOVAREX manufactures a diverse range of product formulations, including tablets, capsules, powders, and stick jellies. A key competitive advantage is its extensive portfolio of individually recognized raw materials, underscoring its focus on scientific innovation and quality.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for the company Novarex. It outlines the date, location, and specific agenda items (such as financial statement approval, dividend approval, and director/auditor appointments). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the upcoming vote, which falls under the Proxy Solicitation & Information Statement category.
2020-03-06 Korean
기타경영사항(자율공시)(식품의약품안전처로부터 건강기능식품 기능성 원료 인정)
Regulatory Filings Classification · 95% confidence The document is a short, voluntary disclosure (자율공시) regarding a regulatory approval (functional ingredient certification from the Ministry of Food and Drug Safety). It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a miscellaneous regulatory announcement regarding business operations, it falls under the RNS (Regulatory Filings) category.
2020-02-28 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Novarex regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2020-02-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Novarex) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for material financial changes. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's availability, it falls under the category of an Earnings Release (ER), which covers initial announcements of financial results.
2020-02-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (DART). It details the sale of shares by an executive (Lee Soo Hyoung) of Novarex. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2020-01-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions or changes in ownership. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and changes in shareholdings by company directors and executives.
2020-01-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.